Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Weight Loss-Induced Metabolic Remodeling in Metabolic dysfunction-associated steatotic liver disease: A Cohort Study Stratified by Genetic Risk. | Clin Nutr | 2026 | 42105611 | PubTator, text mining | PubMed |
| Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease. | Expert Opin Ther Targets | 2026 | 42101442 | PubTator, text mining | PubMed |
Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals. | Open Forum Infect Dis | 2026 | 42100186 | PubTator, text mining | PubMed |
| Clinical Setting Modulates the Association Between Genetic Variants and Fibrosis Severity Across the Spectrum of MASLD. | Liver Int | 2026 | 42093660 | PubTator, text mining | PubMed |
| Analysis of PNPLA3, TM6SF2 and GCKR gene polymorphisms in patients with metabolic dysfunction-associated steatohepatitis treated with probiotics ‒ An exploratory study. | Nutr Hosp | 2026 | 42023869 | PubTator, text mining | PubMed |
| Sex Differences in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Epidemiology, Pathophysiology, and Clinical Implications. | J Clin Exp Hepatol | 2026 | 42022177 | PubTator, text mining | PubMed |
| Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3. | J Hepatol | 2026 | 42009133 | PubTator, text mining | PubMed |
| From Cure to Complexity: Post-SVR Liver and Metabolic Trajectories in Diabetic Patients. | Liver Int | 2026 | 41999061 | PubTator, text mining | PubMed |
| Patatin-Like Phospholipase Domain-Containing Protein 3 rs2896019 and MASLD Susceptibility and Severity in Adults: A Systematic Review and Meta-Analysis of Case-Control Studies. | Metab Syndr Relat Disord | 2026 | 41995081 | PubTator, text mining | PubMed |
| Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype. | Nutrients | 2026 | 41978137 | PubTator, text mining | PubMed |
| Ferritin and Liver Steatosis in Children: Interactions Between Metabolic Clustering and PNPLA3 Variants. | Int J Mol Sci | 2026 | 41977232 | PubTator, text mining | PubMed |
| Metabolic dysfunction-associated steatotic liver disease in Asia: implications on management. | Singapore Med J | 2026 | 41960953 | PubTator, text mining | PubMed |
| Meta-Analysis of Genetic Variants Associated With HBV Infection Susceptibility and Hepatocellular Carcinoma Risk. | J Viral Hepat | 2026 | 41937404 | PubTator, text mining | PubMed |
| Noninvasive Tests for Predicting Decompensation in Compensated Advanced Chronic Liver Disease: A Comprehensive Review. | Liver Int | 2026 | 41934162 | PubTator, text mining | PubMed |
| Attenuated dietary motivation in Wilson's disease correlates with clinical severity. | Orphanet J Rare Dis | 2026 | 41933386 | PubTator, text mining | PubMed |
| Monogenic and Polygenic Risk in Common Liver Diseases: Implications for Clinical Care. | Gastroenterology | 2026 | 41932449 | PubTator, text mining | PubMed |
| Precision medicine in steatotic liver disease. | Curr Opin Gastroenterol | 2026 | 41912348 | PubTator, text mining | PubMed |
Metabolic-associated steatotic liver disease in children and adolescents: a scoping review and narrative synthesis of epidemiology, risk factors, and screening approaches with emerging implications for sub-Saharan Africa. | Front Endocrinol (Lausanne) | 2026 | 41907541 | PubTator, text mining | PubMed |
| Editorial for Special Issue: "Molecular Mechanisms Underlying Fatty Liver Disease: From Pathogenesis to Treatment, 2nd Edition". | Curr Issues Mol Biol | 2026 | 41899440 | PubTator, text mining | PubMed |
| Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma. | Med Sci (Basel) | 2026 | 41892825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=4